Major adverse upper gastrointestinal events in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention and dual antiplatelet therapy

American Journal of Cardiology

Volumn 108, Issue 12, 2011, Pages 1704-1709

  Chen, Yung Lung ^a   Chang, Chia Lo ^a   Chen, Huang Chung ^a   Sun, Cheuk Kwan ^a   Yeh, Kuo Ho ^a   Tsai, Tzu Hsien ^a   Chen, Chien Jen ^a   Chen, Shyh Ming ^a   Yang, Cheng Hsu ^a   Hang, Chi Ling ^a   Wu, Chiung Jen ^a   Yip, Hon Kan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DRUG WITHDRAWAL; DUODENUM ULCER; FEMALE; FOLLOW UP; GASTRODUODENAL ULCER; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STOMACH ULCER; UPPER GASTROINTESTINAL BLEEDING;

AGED; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 82555190948     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.07.039     Document Type: Article

References (25)

1. D.J. Cook, H.D. Fuller, G.H. Guyatt, J.C. Marshall, D. Leasa, R. Hall, T.L. Winton, F. Rutledge, T.J. Todd, P. Roy, J. Lacroix, L. Griffith, A. Willan Canadian Critical Care Trials Group Risk factors for gastrointestinal bleeding in critically ill patients N Engl J Med 330 1994 377 381 (Pubitemid 24045653)
2. D. Cook, D. Heyland, L. Griffith, R. Cook, J. Marshall, J. Pagliarello Canadian Critical Care Trials Group Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation Crit Care Med 27 1999 2812 2817 (Pubitemid 30027202)
3. S.S. Jolly, J. Pogue, K. Haladyn, R.J. Peters, K.A. Fox, A. Avezum, B.J. Gersh, H.J. Rupprecht, S. Yusuf, and S.R. Mehta Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study Eur Heart J 30 2009 900 907
4. F.H. Ng, S.Y. Wong, K.F. Lam, C.M. Chang, Y.K. Lau, W.M. Chu, and B.C. Wong Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome Am J Gastroenterol 103 2008 865 871 (Pubitemid 351501090)
5. H.D. Aronow, S.R. Steinhubl, D.M. Brennan, P.B. Topol, E.J. Berger CREDO Investigators Bleeding risk associated with one year of dual antiplatelet therapy after percutaneous coronary intervention: insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial Am Heart J 157 2009 369 374
6. E. Nikolsky, G.W. Stone, A.J. Kirtane, G.D. Dangas, A.J. Lansky, B. McLaurin, A.M. Lincoff, F. Feit, J.W. Moses, M. Fahy, S.V. Manoukian, H.D. White, E.M. Ohman, M.E. Bertrand, D.A. Cox, and R. Mehran Gastrointestinal bleeding in patients with acute coronary syndromes: Incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol 54 2009 1293 1302
7. D.T. Ko, L. Yun, H.C. Wijeysundera, C.A. Jackevicius, S.V. Rao, P.C. Austin, J.F. Marquis, and J.V. Tu Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years Circ Cardiovasc Interv 3 2010 140 147
8. A.E. Abbas, B. Brodie, S. Dixon, D. Marsalese, S. Brewington, W.W. O'Neill, L.L. Grines, and C.L. Grines Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction Am J Cardiol 96 2005 173 176 (Pubitemid 40978568)
9. T.H. Tsai, S. Chua, H. Hussein, S. Leu, C.J. Wu, C.L. Hang, H.Y. Fang, S.Y. Chung, M. Fu, H.C. Chen, L.T. Chang, K.H. Yeh, and H.K. Yip Outcomes of patients with Killip class III acute myocardial infarction after primary percutaneous coronary intervention Crit Care Med 39 2011 436 442
10. H.K. Yip, C.J. Wu, H.W. Chang, M.C. Chen, C.L. Hang, C.Y. Fang, Y.K. Hsieh, C.H. Yang, K.H. Yeh, and M. Fu Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and evaluation of prognostic determinants Am J Cardiol 87 2001 1184 1188 (Pubitemid 32453240)
11. H.K. Yip, C.J. Wu, H.W. Chang, Y.K. Hsieh, C.Y. Fang, S.M. Chen, and M.C. Chen Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes Chest 124 2003 962 968
12. J.J. Sheu, T.H. Tsai, F.Y. Lee, H.Y. Fang, C.K. Sun, S. Leu, C.H. Yang, S.M. Chen, C.L. Hang, Y.K. Hsieh, C.J. Chen, C.J. Wu, and H.K. Yip Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with STEMI complicated with profound cardiogenic shock Crit Care Med 38 2010 1810 1817
13. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, K.K. Fox Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
14. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, A.J. Kirtane, H. Parise, R. Mehran HORIZONS-AMI Trial Investigators Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230 (Pubitemid 351724451)
15. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 54 2009 2205 2241
16. H. Yasuda, M. Yamada, S. Sawada, Y. Endo, K. Inoue, F. Asano, Y. Takeyama, and M. Yoshiba Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting Intern Med 48 2009 1725 1730
17. D.L. Bhatt, B.L. Cryer, C.F. Contant, M. Cohen, A. Lanas, T.J. Schnitzer, T.L. Shook, P. Lapuerta, M.A. Goldsmith, L. Laine, B.M. Scirica, S.A. Murphy, C.P. Cannon COGENT Investigators Clopidogrel with or without omeprazole in coronary artery disease N Engl J Med 363 2010 1909 1917
18. D.L. Bhatt, J. Scheiman, N.S. Abraham, E.M. Antman, F.K. Chan, C.D. Furberg, D.A. Johnson, K.W. Mahaffey, E.M. Quigley, R.A. Harrington, E.R. Bates, C.R. Bridges, M.J. Eisenberg, V.A. Ferrari, M.A. Hlatky, S. Kaul, J.R. Lindner, D.J. Moliterno, D. Mukherjee, R.S. Schofield, R.S. Rosenson, J.H. Stein, H.H. Weitz, D.J. Wesley American College of Cardiology Foundation; American College of Gastroenterology; American Heart Association ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use Am J Gastroenterol 103 2008 2890 2907
19. G.V. Moukarbel, J.E. Signorovitch, M.A. Pfeffer, J.J. McMurray, H.D. White, A.P. Maggioni, E.J. Velazquez, R.M. Califf, J.M. Scheiman, and S.D. Solomon Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT trial Eur Heart J 30 2009 2226 2232
20. P.M. Ho, T.M. Maddox, L. Wang, S.D. Fihn, R.L. Jesse, E.D. Peterson, and J.S. Rumsfeld Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome JAMA 301 2009 937 944
21. M.W. Chin, G. Yong, M.K. Bulsara, J. Rankin, and G.M. Forbes Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study Am J Gastroenterol 102 2007 2411 2416 (Pubitemid 47631776)
22. M. Moscucci, K.A. Fox, C.P. Cannon, W. Klein, J. López- Sendón, G. Montalescot, K. White, and R.J. Goldberg Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823 (Pubitemid 37280247)
23. E. Schampaert, E.A. Cohen, M. Schlter, F. Reeves, M. Traboulsi, L.M. Title, R.E. Kuntz, J.J. Popma C-SIRIUS Investigators The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS) J Am Coll Cardiol 43 2004 1110 1115 (Pubitemid 38352997)
24. A. Gershlick, I. De Scheerder, B. Chevalier, A. Stephens-Lloyd, E. Camenzind, C. Vrints, N. Reifart, L. Missault, J.J. Goy, J.A. Brinker, A.E. Raizner, P. Urban, and A.W. Heldman Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European Evaluation of Paclitaxel Eluting Stent (ELUTES) trial Circulation 109 2004 487 493 (Pubitemid 38168511)
25. M.C. Morice, P.W. Serruys, P. Barragan, C. Bode, G.A. Van Es, H.P. Stoll, D. Snead, L. Mauri, D.E. Cutlip, and E. Sousa Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial J Am Coll Cardiol 50 2007 1299 1304 (Pubitemid 47454687)